Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells

Eur J Immunol. 1995 Aug;25(8):2285-94. doi: 10.1002/eji.1830250826.

Abstract

Dendritic cells (DC) are the main antigen-presenting cells for the initiation of primary T cell-mediated immune responses. In the first stage of activation, T cells bind to DC in an antigen-independent manner. We studied the adhesion characteristics of human CD4+ T cells to DC generated from CD34+ hematopoietic progenitors following 12 to 13 days of culture in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-alpha. A majority of these cells had the morphology, phenotype and functions of DC. CD4+ T/DC adhesion was measured by means of fluorescence microscopy and flow cytometry. Four independent receptor/ligand pathways, LFA-1/ICAM, ICAM/LFA-1, CD2/LFA-3 and CD28/CD80, were involved in the transient adhesion of DC to CD4+ T cells in antigen-independent and specific alloantigen-dependent situations, as shown by blocking experiments using monoclonal antibodies. The antibodies also blocked a primary mixed lymphocyte reaction (MLR) in which DC were used as stimulatory cells. Adhesion of alloreactive CD4+ T cells to antigen-presenting DC was stronger than that of resting CD4+ T cells, while peak adhesion occurred after 5 and 20 min, respectively. The LFA-1 ligands involved in adhesion of resting CD4 T cells to DC and alloreactive CD4+ T cells to specific DC differed in part, since ICAM-3 on resting T cells and ICAM-1 on alloreactive T lymphocytes preferentially bound LFA-1. Studies of interactions between DC and phorbol ester-activated T cells expressing the CD40 ligand revealed a fifth independent adhesion pathway, CD40/CD40 ligand. CD4-mediated regulation of CD4+ T/DC adhesion was suggested by the observation that preincubation of CD4+ T cells and DC individually with anti-CD4 antibodies inhibited adhesion. In addition, antibodies specific for HLA class II molecules inhibited adhesion when used to pretreat DC but not alloactivated CD4+ T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antigens, CD / immunology
  • Antigens, CD / physiology
  • Antigens, CD1
  • Antigens, CD34
  • Antigens, Differentiation, B-Lymphocyte / immunology
  • Bone Marrow Cells
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD40 Antigens
  • CD40 Ligand
  • Cell Adhesion / immunology*
  • Cell Adhesion Molecules / physiology
  • Cells, Cultured
  • Dendritic Cells / metabolism*
  • Fetal Blood / cytology
  • Granulocyte-Macrophage Colony-Stimulating Factor / physiology
  • HLA-D Antigens / immunology
  • Humans
  • Ionomycin / pharmacology
  • Isoantigens / immunology*
  • Lymphocyte Activation / immunology
  • Lymphocyte Culture Test, Mixed
  • Membrane Glycoproteins / immunology
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD1
  • Antigens, CD34
  • Antigens, Differentiation, B-Lymphocyte
  • CD40 Antigens
  • Cell Adhesion Molecules
  • HLA-D Antigens
  • Isoantigens
  • Membrane Glycoproteins
  • Tumor Necrosis Factor-alpha
  • CD40 Ligand
  • Ionomycin
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Tetradecanoylphorbol Acetate